We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Mean Platelet Volume Determines Crimean-Congo Hemorrhagic Fever Prognosis

By LabMedica International staff writers
Posted on 28 Sep 2015
Print article
Image: The ABBOTT CELL DYN RUBY Hematology Analyzer (Photo courtesy of Abbot Diagnostics).
Image: The ABBOTT CELL DYN RUBY Hematology Analyzer (Photo courtesy of Abbot Diagnostics).
Crimean-Congo hemorrhagic fever virus (CCHF), a Nairovirus within the family Bunyaviridae, causes severe disease and pancytopenia, organ failures and disseminated intravascular coagulation may occur as a result of CCHF infection.

Changes in the mean platelet volume (MPV), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) in patients that have recovered from non-fatal CCHF can be predictors for the duration of hospitalization and prognosis.

Scientists at the Recep Tayyip Erdogan University (Rize, Turkey) studied a total of 50 CCHF patients including 27 males and 23 females and a similar age group of 47 healthy individuals including 27 males and 20 females) were included in the study. Hematologic and biochemical tests inclusive of C-reactive protein were conducted on patients and controls. Blood samples were checked for CCHF nucleic acids by real-time reverse transcriptase polymerase chain reaction (RT-PCR).

Biochemical tests were performed using photometric assays using the Abbott Architect c16000 analyzer (Abbott Diagnostics; Abbott Park, IL, USA). Hematological tests for hemoglobin, platelets, white blood cell counts (WBC), and MPV were performed using the Abbott Cell-Dyn Ruby analyzer. The C-reactive protein (CRP) test was performed using the nephelometric method in the Coulter Image 800 autoanalyzer (Beckman Coulter; Fullerton, CA, USA).

The MPV was statistically higher at 8.4 fL (range 6.4 to 9.4 fL) in patients than that of controls at 7.0 fL (range 6.0 to 8.7 fL). The NLR and PLR were similar in both groups. The predictors of the length of hospitalization included decreased white blood (WBC) cell and platelet counts, together with elevated prothrombin time (PT), creatinine and glucose levels. Bicytopenia and pancytopenia could also be seen in patients with CCHF. In severe cases, neutropenia and severe thrombocytopenia are also frequently encountered.

The authors concluded that the MPV was higher in patients, but NLR and PLR were similar in both groups. The MPV, NLR and PLR did not serve as predictors of hospitalization length. However, elevation of PT, creatinine, glucose, along with decreased WBC and platelets counts were found to be predictors of hospitalization period. The study was published in the September 2015 issue of Journal of Microbiology and Infectious Diseases.

Related Links:

Recep Tayyip Erdogan University
Abbott Diagnostics 
Beckman Coulter


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Xylazine Immunoassay Test
Xylazine ELISA

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: Liquid biopsy could detect and monitor aggressive small cell lung cancer (Photo courtesy of Shutterstock)

Blood-Based Test Detects and Monitors Aggressive Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a highly aggressive type of cancer known for its ability to metastasize. The behavior of tumors is largely governed by which genes are turned on, or transcribed, irrespective... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.